Open clinical trial evaluating the efficacy of a novel eyelash growth enhancer with peptides and glycosaminoglycans

Abstract

AbstractBackgroundEyelashes play a crucial role in self‐image and ocular protection. Enhancements to their structure are of both cosmetic and clinical interest.AimsTo assess the efficacy of a peptide and glycosaminoglycan‐based eyelash enhancer serum in improving eyelash structure.Patients/MethodsThis open‐label clinical trial involved 30 females aged 25–65. Eyelashes were assessed at baseline (D0), 4 weeks (D28), and 12 weeks (D84) using specialized software and high‐resolution imagery. Measurements included lash number, width, length, volume, arc, and angle.ResultsAt 12 weeks, significant increases were observed in lash length (+8.3%), number (+5%), width (+10.1%), volume (+14.1%), arc (+13.4%), and angle (+28.3%) compared to baseline. Global Eyelash Assessment (GEA) scores significantly improved, and patient treatment satisfaction increased from 73.34% at D28 to 84.33% at D84. No adverse effects were reported.ConclusionsThe eyelash growth enhancer serum demonstrated significant efficacy in improving eyelash structure by Week 12, with early signs of improvement evident by Week 4. The high patient satisfaction levels underscore the perceived effectiveness of the product.